Rankings
▼
Calendar
IOBT FY 2021 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena
IOBT
IO Biotech, Inc.
$18M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$41M
Net Income
-$68M
EPS (Diluted)
$-2.36
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$41M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$222M
Total Liabilities
$10M
Stockholders' Equity
$212M
Cash & Equivalents
$212M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$41M
-$10M
-306.4%
Net Income
-$68M
-$12M
-463.7%
← Q4 2020
All Quarters
Q1 2021 →